Hyperhomocyst(e)inemia as a risk factor after renal transplantation

Ann Transplant. 2001;6(4):40-2.

Abstract

Cardiovascular disease (CVD) is one of the leading cause of mortality in renal transplant recipients. Authors review accepted CVD risk factors. The role of additional factors like increased homocysteine level is discussed.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / etiology
  • Folic Acid / therapeutic use
  • Hematinics / therapeutic use
  • Homocysteine / metabolism
  • Humans
  • Hyperhomocysteinemia / complications*
  • Hyperhomocysteinemia / drug therapy
  • Hyperhomocysteinemia / etiology*
  • Kidney Transplantation / adverse effects*
  • Risk Factors

Substances

  • Hematinics
  • Homocysteine
  • Folic Acid